A New Marker for HIV-1 Progression
Adults living with chronic HIV-1 infection carry significantly higher serum levels of torque teno virus (TTV) than those in the primary stage of the disease, according to research published October 29, 2026, in Clinical Microbiology and Infection.
The study identifies TTV as a potential indicator of immune health that conventional CD4 T-cell counts may overlook.
Divergent Viral Loads in French Cohort
Investigators analyzed 126 treatment-naive adults in France between 2018 and 2025. Using immunoblot-based staging, the team categorized 53 participants as having primary HIV-1 infection and 73 as having chronic infection.
The data revealed a stark contrast in viral presence: TTV DNA was detectable in 82.2% of the chronic group, compared to just 32.1% of those with primary infection. The median TTV load reached 4.82 log copies/mL in the chronic cohort, compared to 2.65 log copies/mL in the primary group, as reported by Medscape.
Beyond Traditional Immune Markers
Led by Enagnon Kazali Alidjinou of the Laboratoire de Virologie ULR3610 in Lille, the researchers found that TTV loads offered insights where standard tests fell short. While CD4 T-cell counts remained similar across both cohorts, TTV levels showed an inverse correlation with CD4 counts specifically among chronic patients. "These findings suggest that TTV VL may reflect aspects of immune competence that are not captured by conventional T-cell-based markers," the authors stated.
After adjusting for variables, a TTV load of 4 log copies/mL or higher correlated with an eightfold increase in the odds of a patient having a chronic infection.
Methodology and Scope Constraints
The team employed a quantitative polymerase chain reaction assay to measure TTV DNA. For samples where the virus fell below the threshold of detection, researchers assigned the lower limit of quantification: 2.65 log copies/mL.
The study’s authors acknowledged key limitations, noting that the exact timing of initial HIV-1 exposure remained unknown for participants. The research lacked long-term follow-up and functional immune assays, so future work must determine the clinical implications of these TTV fluctuations.
Defining Infection Stages
To ensure precise classification, the study utilized laboratory-based immunoblot staging. Primary infection was defined as stages I through V, while stage VI was categorized as chronic. The disparity in TTV loads between the two groups persisted regardless of whether a patient’s CD4 count sat above or below 350 cells/µL.
Keep reading